Scabies in healthcare settings

Current Opinion in Infectious Diseases

Volumn 23, Issue 2, 2010, Pages 111-118

  Bouvresse, Sophie ^a   Chosidow, Olivier ^a,b  

^a Hô Pital Henri Mondor ^*  (France)

^b SORBONNE UNIVERSITÉ   (France)

Author keywords

Crusted scabies; Healthcare settings; Outbreak; Scabies

Indexed keywords

BENZYL BENZOATE; CROTAMITON; IVERMECTIN; LINDANE; MALATHION; PERMETHRIN; SULFUR; TEA TREE OIL;

DISINFECTION; DIZZINESS; DRUG EFFICACY; GASTROINTESTINAL SYMPTOM; HUMAN; INFECTION CONTROL; INFECTION RISK; INFESTATION; INSTITUTIONAL CARE; MUSCLE CRAMP; NEUROLOGIC DISEASE; NEUROTOXICITY; NURSING HOME; PARESTHESIA; PATIENT EDUCATION; PATIENT MOBILITY; PRACTICE GUIDELINE; REVIEW; SCABIES; SEIZURE; SINGLE DRUG DOSE; SKIN DISEASE; SKIN IRRITATION; TREATMENT PLANNING;

DISEASE OUTBREAKS; HEALTH FACILITIES; HUMANS; INFECTION CONTROL; INSECTICIDES; PREVALENCE; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SCABIES;

EID: 77649246364     PISSN: 09517375     EISSN: 14736527     Source Type: Journal    
DOI: 10.1097/QCO.0b013e328336821b     Document Type: Review

References (57)

1. Chosidow O. Clinical practices. Scabies. N Engl J Med 2006; 354:171 8-1727.
2. Buehlmann M, Beltraminelli H, Strub C, et al. Scabies outbreak in an intensive care unit with 1,659 exposed individuals: key factors for controlling the outbreak. Infect Control Hosp Epidemiol 2009; 30:354-360.
3. Obasanjo OO, Wu P, Conlon M, et al. An outbreak of scabies in a teaching hospital: lessons learned. Infect Control Hosp Epidemiol 2001; 22:13-18.
4. Papini M, Maccheroni R, Bruni PL. O tempora o mores: the cost of managing institutional outbreaks of scabies. Int J Dermatol 1999; 38:638-639.
5. Holness DL, DeKoven JG, Nethercott JR. Scabies in chronic healthcare institutions. Arch Dermatol 1992; 128:1257-1260.
6. Arlian LG. Biology, host relations, and epidemiology of Sarcoptes scabiei. Annu Rev Entomol 1989; 34:139-161.
7. Argenziano G, Fabbrocini G, Delfino M. Epiluminescence microscopy. A new approach to in vivo detection of Sarcoptes scabiei. Arch Dermatol 1997; 133:751-753.
8. Dupuy A, Dehen L, Bourrat E, et al. Accuracy of standard dermoscopy for diagnosing scabies. J Am Acad Dermatol 2007; 56:53-62.
9. Mounsey KE, Holt DC, McCarthy J, et al. Scabies: molecular perspectives and therapeutic implications in the face of emerging drug resistance. Future Microbiol 2008; 3:57-66.
10. Walton SF, Myerscough MR, Currie BJ. Studies in vitro on the relative efficacy of current acaricides for Sarcoptes scabiei var. hominis. Trans R Soc Trop Med Hyg 2000; 94:92-96.
11. Roth WI. Scabies resistant to lindane 1% lotion and crotamiton 10% cream. J Am Acad Dermatol 1991; 24:502-503.
12. Purvis RS, Tyring SK. An outbreak of lindane-resistant scabies treated successfully with permethrin 5% cream. J Am Acad Dermatol 1991; 25: 1015-1016.
13. Moberg SA, Lowhagen GB, Hersle KS. An epidemic of scabies with unusual features and treatment resistance in a nursing home. J Am Acad Dermatol 1984; 11:242-244.
14. Taplin D, Meinking TL, Chen JA, Sanchez R. Comparison of crotamiton 10% cream (Eurax) and permethrin 5% cream (Elimite) for the treatment of scabies in children. Pediatr Dermatol 1990; 7:67-73.
15. Amer M, el-Gharib I. Permethrin versus crotamiton and lindane in the treatment of scabies. Int J Dermatol 1992; 31:357-358.
16. Walton SF, McKinnon M, Pizzutto S, et al. Acaricidal activity of Melaleuca alternifolia (tea tree) oil: in vitro sensitivity of Sarcoptes scabiei var hominis to terpinen-4-ol. Arch Dermatol 2004; 140:563-566.
17. Yeruham I, Hadani A. Control of human scabies by topical application of ivermectin. Ann Trop Med Parasitol 1998; 92:627-629.
18. Victoria J, Trujillo R. Topical ivermectin: a new successful treatment for scabies. Pediatr Dermatol 2001; 18:63-65.
19. Strong M, Johnstone PW. Interventions for treating scabies. Cochrane Database Syst Rev 2007:CD000320.
20. Currie BJ, Harumal P, McKinnon M, et al. First documentation of in vivo and in vitro ivermectin resistance in Sarcoptes scabiei. Clin Infect Dis 2004; 39:e8-e12.
21. Burkhart CG, Burkhart CN, Burkhart KM. An epidemiologic and therapeutic reassessment of scabies. Cutis 2000; 65:233-240.
22. Usha V, Gopalakrishnan Nair TV. A comparative study of oral ivermectin and topical permethrin cream in the treatment of scabies. J Am Acad Dermatol 2000; 42:236-240.
23. Ly F, Caumes E, Ndaw CA, et al. Ivermectin versus benzyl benzoate applied once or twice to treat human scabies in Dakar, Senegal: a randomized controlled trial. Bull World Health Organ 2009; 87:424-430.
24. Lawrence G, Leafasia J, Sheridan J, et al. Control of scabies, skin sores and haematuria in children in the Solomon Islands: another role for ivermectin. Bull World Health Organ 2005; 83:34-42.
25. Marty P, Gari-Toussaint M, Le Fichoux Y, Gaxotte P. Efficacy of ivermectin in the treatment of an epidemic of sarcoptic scabies. Ann Trop Med Parasitol 1994; 88:453. (Pubitemid 24292273)
26. Barkwell R, Shields S. Deaths associated with ivermectin treatment of scabies. Lancet 1997; 349:1144-1145.
27. Chan LY, Tang WY, Ho HH, Lo KK. Crusted (Norwegian) scabies in two old-age home residents. Hong Kong Med J 2000; 6:428-430.
28. Andersen BM, Haugen H, Rasch M, et al. Outbreak of scabies in Norwegian nursing homes and home care patients: control and prevention. J Hosp Infect 2000; 45:160-164.
29. De Beer G, Miller MA, Tremblay L, Monette J. An outbreak of scabies in a long-term care facility: the role of misdiagnosis and the costs associated with control. Infect Control Hosp Epidemiol 2006; 27:517-518.
30. Degelau J. Scabies in long-term care facilities. Infect Control Hosp Epidemiol 1992; 13:421-425.
31. Clark J, Friesen DL, Williams WA. Management of an outbreak of Norwegian scabies. Am J Infect Control 1992; 20:217-220.
32. Garcia C, Iglesias D, Terashima A, et al. Use of ivermectin to treat an institutional outbreak of scabies in a low-resource setting. Infect Control Hosp Epidemiol 2007; 28:1337-1338.
33. Larrosa A, Cortes-Blanco M, Martinez S, et al. Nosocomial outbreak of scabies in a hospital in Spain. Euro Surveill 2003; 8:1 99-203.
34. Zafar AB, Beidas SO, Sylvester LK. Control of transmission of Norwegian scabies. Infect Control Hosp Epidemiol 2002; 23:278-279.
35. Pruksachatkunakorn C, Wongthanee A, Kasiwat V. Scabies in Thai orphanages. Pediatr Int 2003; 45:724-727.
36. Lettau LA. Nosocomial transmission and infection control aspects of parasitic and ectoparasitic diseases. Part III. Ectoparasites/summary and conclusions. Infect Control Hosp Epidemiol 1991; 12:179-185.
37. Pennington NE. Scabies: an itchy problem. Michigan Department of Public Health-EOH. Focus 1986; 2:9.
38. Anonymous. La gale dans les etablissements pour personnes agees en France en 1996. BEH 1997; 7:27-29.
39. Makigami K, Ohtaki N, Ishii N, Yasumura S. Risk factors of scabies in psychiatric and long-term care hospitals: a nationwide mail-in survey in Japan. J Dermatol 2009; 36:491-498.
40. Vorou R, Remoudaki HD, Maltezou HC. Nosocomial scabies. J Hosp Infect 2007; 65:9-14.
41. Smith P, Bennett G, Bradley S, et al. SHEA/APIC guideline: infection prevention and control in the long-term care facility. Am J Infect Control 2008; 36:504-535.
42. Van Vliet JA, Samsom M, van Steenbergen JE. Causes of spread and return of scabies in healthcare institutes: literature analysis of 44 epidemics. Ned Tijdschr Geneeskd 1998; 142:354-357.
43. Achtari Jeanneret L, Erard P, Gueissaz F, Malinverni R. An outbreak of scabies: a forgotten parasitic disease still present in Switzerland. Swiss Med Wkly 2007; 137:695-699.
44. Tsutsumi M, Nishiura H, Kobayashi T. Dementia-specific risks of scabies: retrospective epidemiologic analysis of an unveiled nosocomial outbreak in Japan from 1989-1990. BMC Infect Dis 2005; 5:85.
45. Jimenez-Lucho VE, Fallon F, Caputo C, Ramsey K. Role of prolonged surveillance in the eradication of nosocomial scabies in an extended care Veterans Affairs medical center. Am J Infect Control 1995; 23:44-49.
46. Juranek DD, Currier RW, Millikan LE. Scabies control in institutions. In: Orkin M, editor. Cutaneous infestations and insect bites. Maiback HI, New York: Dekker; 1985.
47. Gil AJ, Aparici CD, Salazar CA, et al. Brote de sarna en personal sanitario. Enfermeŕia Integral 1999; 48.
48. Pasternak J, Richtmann R, Ganme AP, et al. Scabies epidemic: price and prejudice. Infect Control Hosp Epidemiol 1994; 15:540-542.
49. Roberts LJ, Huffam SE, Walton SF, Currie BJ. Crusted scabies: clinical and immunological findings in seventy-eight patients and a review of the literature. J Infect 2005; 50:375-381.
50. Meyers LN. Clinical presentation of scabies in a nursing home population. J Am Acad Dermatol 1988; 18:396-397.
51. Robles Garcia M, de la Lama Lopez-Areal J, Avellaneda Martinez C, et al. Nosocomial scabies outbreak. Rev Clin Esp 2000; 200:538-542.
52. Scheinfeld N. Controlling scabies in institutional settings: a review of medications, treatment models, and implementation. Am J Clin Dermatol 2004; 5:31-37.
53. Tjioe M, Vissers WH. Scabies outbreaks in nursing homes for the elderly: recognition, treatment options and control of reinfestation. Drugs Aging 2008; 25:299-306.
54. Castor C, Bernadou I. Epidemie de gale communautaire-Guide d'investigation et d'aide a la gestion. Saint-Maurice (France): Institut de veille sanitaire. http://www.invs.sante.fr/publications/2008/epidemie-gale- commmunautaire/index.html. [Accessed at 2008]
55. Estes SA, Estes J. Therapy of scabies: nursing homes, hospitals, and the homeless. Semin Dermatol 1993; 12:26-33.
56. Corbett EL, Crossley I, Holton J, et al. Crusted ('Norwegian') scabies in a specialist HIV unit: successful use of ivermectin and failure to prevent nosocomial transmission. Genitourin Med 1996; 72:115-117.
57. Chosidow O. Scabies and pediculosis. Lancet 2000; 355:819-826.